Trademarkia Logo

Canada

C$
MULTABODY
FORMALIZED

on 18 Sept 2024

Last Applicant/ Owned by

Radiant Biotherapeutics

PGCRL 21.9430.X, Admin Rm 21.9800 U1 E686 Bay StreetToronto ON M5G 0A4

CA

Serial Number

2350275 filed on 9th Jan 2024

Correspondent Address

CHANTAL ST. DENIS

(O'BRIEN TM SERVICES INC)262, chemin EardleyGatineau

QUEBEC

CA

J9J2Y7

MULTABODY

Trademark usage description

chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monov Read More

Classification Information


Class [001]
Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, bi- and multispecific antibodies as well as fragments, monovalent antibodies, derivatives of conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; biochemicals, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer, AIDS (acquired immune deficiency syndrome), and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases.


Classification kind code

12

Class [005]
Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, bi and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases; pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases.


Classification kind code

12

Class [042]
Medical, scientific and biological research; research in antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies, bi and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; development of pharmaceuticals containing antibodies, bi- and multispecific antibodies or fragments, monovalent antibodies, derivatives or conjugates of any of these; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research and development; medical and scientific research, namely, biological scientific research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for the treatment of cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies.


Classification kind code

12

Class [045]
Legal services in the form of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine.


Classification kind code

12

Mark Details


Serial Number

2350275

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 14th Nov 2024
Agent Changed
Submitted for opposition 257
on 19th Sept 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 18th Sept 2024
Created
Submitted for opposition 31
on 18th Sept 2024
Formalized
Submitted for opposition 30
on 9th Jan 2024
Filed
Submitted for opposition 228
on 9th Jan 2024
International Registration